Search research articles
Contact Us
Filters
Showing results (201-210 of 346) with videos related to
Page
of 35
Sort By:
Cancers
|
January 11, 2022
Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Amber Gibson, Adriana Trabal, David McCall, et al.
Blood Cancer Journal
|
January 26, 2022
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy
Sangeetha Venugopal, Koichi Takahashi, Naval Daver, et al.
Blood Advances
|
January 24, 2025
TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation
Konstantinos Lontos, Rima M Saliba, Rashmi Kanagal-Shamanna, et al.
Journal of Hematology & Oncology
|
November 16, 2024
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis
Samuel Urrutia, Hagop M Kantarjian, Farhad Ravandi-Kashani, et al.
American Journal of Hematology
|
May 17, 2026
Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALL
Sankalp Arora, Hagop Kantarjian, Koji Sasaki, et al.
Cancer
|
March 9, 2023
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation
Daniel Nguyen, Hagop M Kantarjian, Nicholas J Short, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 9, 2026
Comprehensive Cytogenomic Profiling of T-Lymphoblastic Leukemia by Optical Genome Mapping, Karyotyping and Next Generation Sequencing
Guilin Tang, Alexandra Reynolds, Farhad Ravandi-Kashani, et al.
American Journal of Hematology
|
December 24, 2024
Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation
Jayastu Senapati, Hagop M Kantarjian, Fadi G Haddad, et al.
American Journal of Hematology
|
April 12, 2022
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials
Kunhwa Kim, Marina Konopleva, Courtney D DiNardo, et al.
Cancer
|
July 13, 2021
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax
Kunhwa Kim, Abhishek Maiti, Sanam Loghavi, et al.
Page
of 35
Search research articles
Search
Showing results (201-210 of 346) with videos related to
Sort By:
Page
of 35
Cancers
|
January 11, 2022
Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Amber Gibson, Adriana Trabal, David McCall, et al.
Blood Cancer Journal
|
January 26, 2022
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy
Sangeetha Venugopal, Koichi Takahashi, Naval Daver, et al.
Blood Advances
|
January 24, 2025
TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation
Konstantinos Lontos, Rima M Saliba, Rashmi Kanagal-Shamanna, et al.
Journal of Hematology & Oncology
|
November 16, 2024
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis
Samuel Urrutia, Hagop M Kantarjian, Farhad Ravandi-Kashani, et al.
American Journal of Hematology
|
May 17, 2026
Predictors of Relapse and Post-Relapse Outcomes After Frontline Blinatumomab in Philadelphia Chromosome-Negative B-ALL
Sankalp Arora, Hagop Kantarjian, Koji Sasaki, et al.
Cancer
|
March 9, 2023
Early mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation
Daniel Nguyen, Hagop M Kantarjian, Nicholas J Short, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 9, 2026
Comprehensive Cytogenomic Profiling of T-Lymphoblastic Leukemia by Optical Genome Mapping, Karyotyping and Next Generation Sequencing
Guilin Tang, Alexandra Reynolds, Farhad Ravandi-Kashani, et al.
American Journal of Hematology
|
December 24, 2024
Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation
Jayastu Senapati, Hagop M Kantarjian, Fadi G Haddad, et al.
American Journal of Hematology
|
April 12, 2022
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials
Kunhwa Kim, Marina Konopleva, Courtney D DiNardo, et al.
Cancer
|
July 13, 2021
Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax
Kunhwa Kim, Abhishek Maiti, Sanam Loghavi, et al.
Page
of 35